Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study.
Nozari Y, Vosooghi S, Boroumand M, Poorhosseini H, Nematipour E, Salarifar M, Kassaian SE, Amirzadegan A, Alidoosti M, Haji-Zeinali AM, Saroukhani S. Nozari Y, et al. Among authors: saroukhani s. Anatol J Cardiol. 2015 May;15(5):348-53. doi: 10.5152/akd.2014.5418. Anatol J Cardiol. 2015. PMID: 25993709 Free PMC article.
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.
Poorhoseini HR, Kassaian SE, Hoseini K, Saroukhani S, Salarifar M, Alidoosti M, Nematipour E, Haji-Zeinali AM, Amirzadegan A, Seyyed Mohammadzadeh MH, Khadem Vatan K, Aghajani H, Sheikh Fathollahi M, Farrokh-Eslamlou H. Poorhoseini HR, et al. Among authors: saroukhani s. Ther Adv Cardiovasc Dis. 2016 Aug;10(4):206-13. doi: 10.1177/1753944716629868. Epub 2016 Feb 7. Ther Adv Cardiovasc Dis. 2016. PMID: 26857928 Free PMC article.
A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention.
Kassaian SE, Saroukhani S, Alaeddini F, Salarifar M, Capodanno D, Poorhoseini H, Lotfi-Tokaldany M, Leesar MA, Aghajani H, Hakki-Kazzazi E, Alidoosti M, Haji-Zeinali AM, Saifi M, Nematipour E. Kassaian SE, et al. Among authors: saroukhani s. J Tehran Heart Cent. 2015 Oct 27;10(4):167-75. J Tehran Heart Cent. 2015. PMID: 26985204 Free PMC article.
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.
Parsa E, Saroukhani S, Majlessi F, Poorhosseini H, Lofti-Tokaldany M, Jalali A, Salarifar M, Nematipour E, Alidoosti M, Aghajani H, Amirzadegan A, Kassaian SE. Parsa E, et al. Among authors: saroukhani s. Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr. Tex Heart Inst J. 2016. PMID: 27127426 Free PMC article.
Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.
Alidoosti M, Saroukhani S, Lotfi-Tokaldany M, Jalali A, Sobh-Rakhshankhah A. Alidoosti M, et al. Among authors: saroukhani s. Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):308-12. doi: 10.1016/j.carrev.2016.03.009. Epub 2016 Mar 28. Cardiovasc Revasc Med. 2016. PMID: 27198530
Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors.
Kassaian SE, Fathi Y, Lotfi-Tokaldany M, Salarifar M, Alidoosti M, Haji-Zeinali AM, Aghajani H, Amirzadegan A, Nozari Y, Mortazavi SH, Jalali A, Saroukhani S. Kassaian SE, et al. Among authors: saroukhani s. Crit Pathw Cardiol. 2016 Sep;15(3):89-94. doi: 10.1097/HPC.0000000000000079. Crit Pathw Cardiol. 2016. PMID: 27465002
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.
Shahmansouri N, Farokhnia M, Abbasi SH, Kassaian SE, Noorbala Tafti AA, Gougol A, Yekehtaz H, Forghani S, Mahmoodian M, Saroukhani S, Arjmandi-Beglar A, Akhondzadeh S. Shahmansouri N, et al. Among authors: saroukhani s. J Affect Disord. 2014 Feb;155:216-22. doi: 10.1016/j.jad.2013.11.003. Epub 2013 Nov 16. J Affect Disord. 2014. PMID: 24289892 Clinical Trial.
39 results